Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Arzneimittel-Forschung|October 19, 2005
High performance liquid chromatographic analysis an pharmacokinetic characteristics of ID-7181, a novel quaternary ammoniopropenyl cephalosporin, following intravenous and intramuscular injections to ratsBo-Im Yoo, Zi Ho Yeom, Min Hee Kanga, et al.Molecular Cancer Research : MCR|June 18, 2009
Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}BJung Ok Ban, Hee Soon Lee, Heon-Sang Jeong, et al.Archives of Pharmacal Research|May 11, 2007
Sphingosine 1-phosphate and sphingosine kinase activity during chicken embryonic developmentChang-Hwan Choi, Ji-Seon Jeong, Bo-im Yoo, et al.Archives of Pharmacal Research|May 28, 2009
Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxelSun Mi Kim, So Yong Lee, Dong Yeon Yuk, et al.Biochemical and Biophysical Research Communications|December 23, 2009
Carabrol suppresses LPS-induced nitric oxide synthase expression by inactivation of p38 and JNK via inhibition of I-kappaBalpha degradation in RAW 264.7 cellsHwa Jin Lee, Hyo Jin Lim, Da Yeon Lee, et al.International Journal of Oncology|April 11, 2009
Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cellsMyoung Suk Choi, Ju Hoon Oh, Sun Mi Kim, et al.European Journal of Pharmacology|September 28, 2010
Neurotrophic activity of obovatol on the cultured embryonic rat neuronal cells by increase of neurotrophin release through activation of ERK pathwayYong Kyoung Lee, Ju Kyoung Song, Im Seop Choi, et al.Journal of Pharmaceutical and Biomedical Analysis|February 24, 2012
Determination of a novel TAZ modulator, 2-butyl-5-methyl-6-(pyridine-3-yl)-3-[2'-(1H-tetrazole-5-yl)-biphenyl-4-ylmethyl]-3H imidazo[4,5-b]pyridine] (TM-25659) in rat plasma by liquid chromatography-tandem mass spectrometrySung Heum Choi, Kyeong-Ryoon Lee, Jae-Chun Woo, et al.Biochemical and Biophysical Research Communications|July 14, 2004
EPO receptor-mediated ERK kinase and NF-kappaB activation in erythropoietin-promoted differentiation of astrocytesSang Min Lee, Thi Hong Nga Nguyen, Mi Hee Park, et al.Cancer Biology & Therapy|May 27, 2011
Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expressionJung Ok Ban, Ju Hoon Oh, Seung Mo Son, et al.Pageof 7